Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes
- PMID: 2775784
- DOI: 10.1016/0005-2736(89)90307-6
Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes
Abstract
Recently we reported that serum contains opsonins specific for hepatic and splenic phagocytic cells and that these opsonins have different properties and affinities for cholesterol-rich and cholesterol-free egg phosphatidylcholine liposomes (Moghimi, S.M. and Patel, H.M. (1988) FEBS Lett. 233, 143-147). In the present report we investigate the affinity of these opsonins for the liposomes prepared from sphingomyelin and saturated phospholipids, as measured by their effect on the uptake of these liposomes by hepatic and splenic phagocytic cells. Results presented here suggest that neither liver- nor spleen-specific opsonins have affinity for sphingomyelin or saturated phospholipid liposomes since serum fails to enhance their uptake in liver or splenic cells. On the contrary, these liposomes attract serum dysopsonins which inhibit their uptake by liver cells. Inclusion of cholesterol in these liposome preparations enhances their uptake in splenic cells but not in liver cells. It is suggested that fluidity and hydrophobicity of liposomal membranes play an important role in attracting the right opsonins which determine their phagocytic fate.
Similar articles
-
Differential properties of organ-specific serum opsonins for liver and spleen macrophages.Biochim Biophys Acta. 1989 Sep 18;984(3):379-83. doi: 10.1016/0005-2736(89)90306-4. Biochim Biophys Acta. 1989. PMID: 2775783
-
Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes.FEBS Lett. 1988 Jun 6;233(1):143-7. doi: 10.1016/0014-5793(88)81372-3. FEBS Lett. 1988. PMID: 3384086
-
Opsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cells.Biochim Biophys Acta. 1992 Jun 29;1135(3):269-74. doi: 10.1016/0167-4889(92)90230-9. Biochim Biophys Acta. 1992. PMID: 1623013
-
Serum opsonins and liposomes: their interaction and opsonophagocytosis.Crit Rev Ther Drug Carrier Syst. 1992;9(1):39-90. Crit Rev Ther Drug Carrier Syst. 1992. PMID: 1544174 Review.
-
Liposome clearance.Biosci Rep. 2002 Apr;22(2):197-224. doi: 10.1023/a:1020134521778. Biosci Rep. 2002. PMID: 12428901 Review.
Cited by
-
Polymer-tethered glycosylated gold nanoparticles recruit sialylated glycoproteins into their protein corona, leading to off-target lectin binding.Nanoscale. 2022 Sep 22;14(36):13261-13273. doi: 10.1039/d2nr01818g. Nanoscale. 2022. PMID: 36053227 Free PMC article.
-
Monosialoganglioside GM1 shortens the blood circulation time of liposomes in rats.Pharm Res. 1995 Apr;12(4):508-12. doi: 10.1023/a:1016289526578. Pharm Res. 1995. PMID: 7596984
-
Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases.Eye (Lond). 2020 Aug;34(8):1341-1356. doi: 10.1038/s41433-020-0770-y. Epub 2020 Jan 30. Eye (Lond). 2020. PMID: 32001821 Free PMC article. Review.
-
Could a Non-Cellular Molecular Interactome in the Blood Circulation Influence Pathogens' Infectivity?Cells. 2023 Jun 23;12(13):1699. doi: 10.3390/cells12131699. Cells. 2023. PMID: 37443732 Free PMC article. Review.
-
Magnetic resonance molecular imaging with nanoparticles.J Nucl Cardiol. 2004 Nov-Dec;11(6):733-43. doi: 10.1016/j.nuclcard.2004.09.002. J Nucl Cardiol. 2004. PMID: 15592197 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources